Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Nowy Sacz

8 clinical trials in Nowy Sacz, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Nowy Sacz at a glance
8
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

8 trials in Nowy Sacz

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Merck Sharp & Dohme LLC
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Myelofibrosis

Recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Navtemadlin
  • Sponsor:Kartos Therapeutics Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Belantamab Mafodotin
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Celgene Corp.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Rophibio Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:Incyte Corp.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Danazol
  • Sponsor:Sobi Inc.

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Nowy Sacz

What the registry says about research in the country

01 Hematologic Oncology

Innovative research focusing on Multiple Myeloma treatments, evaluating novel therapeutic combinations and alternative dosing regimens to improve patient outcomes.

  • Belantamab mafodotin studies
  • Iberdomide combination therapy
  • Diffuse Large B-Cell Lymphoma research

Clinical investigations aim to enhance treatment efficacy while monitoring patient safety and response rates.

02 Blood Disorders

Research examining treatments for Primary Immune Thrombocytopenia and various forms of Myelofibrosis, including novel therapeutic approaches.

  • Efgartigimod IV therapy
  • Pacritinib efficacy studies
  • Disease control assessment

Studies focus on measuring specific outcomes such as spleen volume reduction and symptom improvement.

03 Ophthalmology

Clinical research targeting neovascular age-related macular degeneration, comparing the effectiveness of different treatment options.

  • Vision improvement assessment
  • Treatment equivalence studies
  • Visual acuity measurements

Trials evaluate new therapeutic options against established treatments for better patient care outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.